I. Katsikis

发表

Peroxisome proliferator‐activated receptor‐γ and ‐δ polymorphisms in women with polycystic ovary syndrome

M. Gazouli, E. Diamanti-Kandarakis, G. Creatsas, 2010, Annals of the New York Academy of Sciences.

Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2007, Metabolism: clinical and experimental.

Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.

I. Katsikis, D. Panidis, D. Macut, 2012, Fertility and sterility.

The bencfit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2014, Hormones.

Inflammatory and endothelial markers in women with polycystic ovary syndrome

J. Lekakis, A. Protogerou, E. Diamanti-Kandarakis, 2006, European journal of clinical investigation.

Vaspin: a novel adipokine, member of the family of serine protease inhibitors

E. Kalaitzakis, I. Katsikis, D. Panidis, 2011 .

Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.

I. Katsikis, D. Panidis, D. Macut, 2012, Human reproduction.

Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system.

I. Katsikis, D. Panidis, M. Kita, 2008, Hippokratia.

The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study

I. Katsikis, D. Panidis, E. Tsourdi, 2010, Reproductive biology and endocrinology : RB&E.

Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndrome.

I. Katsikis, D. Panidis, D. Macut, 2006, European journal of obstetrics, gynecology, and reproductive biology.

Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.

I. Katsikis, D. Panidis, D. Macut, 2009, American journal of physiology. Endocrinology and metabolism.

The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.

I. Katsikis, D. Panidis, E. Tsourdi, 2013, European journal of endocrinology.

Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility

I. Katsikis, D. Panidis, K. Tziomalos, 2013, Endocrine.

Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome.

I. Katsikis, D. Panidis, E. Tsourdi, 2013, European journal of endocrinology.

The impact of oral contraceptives and metformin on anti-Müllerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia

N. Georgopoulos, E. Diamanti-Kandarakis, A. Saltamavros, 2011, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Infertility treatment in polycystic ovary syndrome: lifestyle interventions, medications and surgery.

I. Katsikis, D. Panidis, K. Tziomalos, 2013, Frontiers of hormone research.

Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

A. Papavassiliou, E. Diamanti-Kandarakis, I. Katsikis, 2008, Clinical endocrinology.

Genetics of polycystic ovary syndrome.

I. Katsikis, D. Panidis, I. Kalogiannidis, 2009, Hippokratia.

Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients.

I. Katsikis, D. Panidis, D. Macut, 2009, Fertility and sterility.

Associations of menstrual cycle irregularities with age, obesity and phenotype in patients with polycystic ovary syndrome

I. Katsikis, D. Panidis, E. Tsourdi, 2015, Hormones.

Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.

A. Papavassiliou, S. Livadas, E. Diamanti-Kandarakis, 2009, European journal of endocrinology.

The Phenotypes of Polycystic Ovary Syndrome Defined by the 1990 Diagnostic Criteria Are Associated with Higher Serum Vaspin Levels than the Phenotypes Introduced by the 2003 Criteria

K. Toulis, I. Katsikis, D. Panidis, 2011, Obesity Facts.

The influence of tibolone upon serum leptin levels in post-menopausal women.

I. Katsikis, D. Panidis, K. Stergiopoulos, 2001, European journal of obstetrics, gynecology, and reproductive biology.

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome

I. Katsikis, D. Panidis, E. Tsourdi, 2014, Clinical endocrinology.

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study

G. Nassis, N. Georgopoulos, E. Diamanti-Kandarakis, 2008, International Journal of Obesity.

Serum luteinizing hormone levels are markedly increased and significantly correlated with Delta 4-androstenedione levels in lean women with polycystic ovary syndrome.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2005, Fertility and sterility.

Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?

M. Gazouli, E. Diamanti-Kandarakis, G. Creatsas, 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome.

I. Katsikis, D. Panidis, K. Tziomalos, 2011, Endocrine journal.

Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.

I. Katsikis, D. Panidis, D. Farmakiotis, 2008, Fertility and sterility.

Plasma visfatin levels in normal weight women with polycystic ovary syndrome.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2008, European journal of internal medicine.

Μechanisms of infertility in polycystic ovary syndrome

I. Katsikis, D. Panidis, M. Kita, 2007 .

Reproductive endocrinology Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome

I. Katsikis, D. Panidis, D. Macut, 2016 .

Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.

I. Katsikis, D. Panidis, D. Macut, 2016, Human reproduction.

The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.

I. Katsikis, D. Panidis, D. Farmakiotis, 2008, Atherosclerosis.

Uterine volume and endometrial thickness in the early follicular phase in patients with polycystic ovary syndrome.

I. Katsikis, D. Panidis, K. Tziomalos, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome

I. Katsikis, D. Panidis, K. Tziomalos, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels.

I. Katsikis, D. Panidis, E. Tsourdi, 2011, European Journal of Endocrinology.

Effect of long‐term orlistat treatment on serum levels of advanced glycation end‐products in women with polycystic ovary syndrome

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2006, Clinical endocrinology.

Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2006, Fertility and sterility.

Oligo-ovulation or anovulation and hyperandrogenemia contribute to the decreased serum adiponectin levels in normal-weight women with PCOS with obesity and insulin resistance.

N. Georgopoulos, I. Katsikis, D. Panidis, 2009, Fertility and sterility.

Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome

A. Papavassiliou, S. Livadas, E. Diamanti-Kandarakis, 2010, Journal of Bone and Mineral Metabolism.

Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2005, Human reproduction.

Decreased active, total and altered active to total ghrelin ratio in normal weight women with the more severe form of polycystic ovary syndrome.

N. Georgopoulos, E. Diamanti-Kandarakis, A. Saltamavros, 2010, European journal of obstetrics, gynecology, and reproductive biology.

Serum and seminal plasma ghrelin levels in men with normospermia and dyspermia

D. Goulis, N. Georgopoulos, E. Diamanti-Kandarakis, 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)

A. Armeni, N. Roupas, N. Georgopoulos, 2014, Hormones.

The influence of obesity on Androstenedione to Testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia

A. Armeni, N. Roupas, N. Georgopoulos, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Long-term follow-up of combined pituitary hormone deficiency in two siblings with a Prophet of Pit-1 gene mutation

V. Koika, G. Adonakis, N. Georgopoulos, 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

CYP21A2 mutations in women with polycystic ovary syndrome (PCOS).

G. Chrousos, I. Katsikis, D. Panidis, 2013, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration

I. Katsikis, D. Panidis, K. Tziomalos, 2013, Hormones.

The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.

I. Katsikis, D. Panidis, D. Farmakiotis, 2007, Fertility and sterility.

The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia.

M. Salmas, I. Katsikis, D. Panidis, 2009, Fertility and sterility.

Is the Y chromosome all that is required for sex determination?

I. Katsikis, D. Panidis, M. Kita, 2007, Hippokratia.

Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome.

I. Katsikis, D. Panidis, D. Delkos, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Late pregnancy complications in polycystic ovarian syndrome.

I. Katsikis, D. Panidis, M. Kita, 2006, Hippokratia.

Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome

M. Gazouli, G. Creatsas, P. Christopoulos, 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2005, Clinical chemistry.

Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)

N. Roupas, N. Georgopoulos, I. Katsikis, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Serum AMH, FSH, and LH levels in PCOS.

N. Georgopoulos, A. Saltamavros, G. Decavalas, 2010, Fertility and sterility.

Receiver operator characteristics and diagnostic value of progesterone and CA-125 in the prediction of ectopic and abortive intrauterine gestations.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2006, European journal of obstetrics, gynecology, and reproductive biology.

Adenomyosis: what is the impact on fertility?

I. Katsikis, D. Panidis, I. Matalliotakis, 2005, Current opinion in obstetrics & gynecology.

Creatine phosphokinase in ectopic pregnancy revisited: significant diagnostic value of its MB and MM isoenzyme fractions.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2006, American Journal of Obstetrics and Gynecology.

Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome

I. Katsikis, D. Panidis, E. Tsourdi, 2013, Hormones.

Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.

I. Katsikis, D. Panidis, E. Tsourdi, 2012, Endocrine journal.

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.

E. Diamanti-Kandarakis, I. Katsikis, D. Panidis, 2006, Human reproduction.

Prevalence of metabolic syndrome in women with polycystic ovary syndrome

I. Katsikis, D. Panidis, E. Tsourdi, 2013, Clinical endocrinology.

Plasma Von Willebrand factor antigen levels are elevated in the classic phenotypes of polycystic ovary syndrome

I. Katsikis, D. Panidis, E. Tsourdi, 2012, Hormones.

Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.

D. Goulis, K. Toulis, B. Tarlatzis, 2009, Human reproduction update.

menopausal women markers of premature coronary calcification in newly Characterization of blood borne microparticles as

M. Budoff, P. Araoz, V. Miller, 2011 .

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.

I. Katsikis, D. Panidis, D. Macut, 2013, Human reproduction.

Calcium homeostasis and anovulatory infertility.

I. Katsikis, D. Panidis, D. Farmakiotis, 2007, Human reproduction.

Weight loss significantly reduces serum lipocalin-2 levels in overweight and obese women with polycystic ovary syndrome

I. Katsikis, D. Panidis, K. Tziomalos, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

POSTER VIEWING SESSION - FEMALE (IN) FERTILITY

S. Campbell, H. Steiner, B. Mol, 2011 .

Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels.

A. Armeni, N. Georgopoulos, I. Katsikis, 2011, Medical hypotheses.

Mechanisms of infertility in polycystic ovary syndrome

I. Katsikis, D. Panidis, M. Kita, 2006 .

Anovulation and ovulation induction.

I. Katsikis, D. Panidis, M. Kita, 2006, Hippokratia.

Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis

D. Goulis, G. Mintziori, J. Kountouras, 2002, Hormones.

Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome

I. Katsikis, D. Panidis, E. Tsourdi, 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Sibutramine administration decreases serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome.

A. Armeni, N. Roupas, N. Georgopoulos, 2012, European journal of obstetrics, gynecology, and reproductive biology.

Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome

T. Simić, I. Katsikis, D. Panidis, 2014, Hormones.